Citadel Advisors

Citadel Advisors’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Citadel Advisors’s Portfolio DALS Stock Details DALS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$5.99M	Sell
2023 Q1	$7.36M	Buy
2022 Q4	$7.21M	Buy
2022 Q3	$6.99M	Buy
2022 Q2	$6.99M	Buy
2022 Q1	$5.81M	Buy
2021 Q4	$5.85M	Sell
2021 Q3	$6.01M	Buy